Business - Briefly   

Tentative nod for Aurobindo pharma drug

HYDERABAD: Aurobindo Pharma has announced the receipt of tentative approval for its Zidovudine 300 mg tablets from the U.S. Food and Drug Administration. This makes the company qualify under the President's Emergency Plan for AIDS relief (PEPFAR) program for Zidovudine 300 mg.

Printer friendly page  
Send this article to Friends by E-Mail

Stories in this Section

New drug pricing policy proposed
Industry supports hike in petroproduct prices
LIC to forge alliance for overseas forays
LG's second unit in Pune
Mixed reaction to China, EU textile accord
ITC Foods to raise capacity
U.S. help in agri research sought
Government agencies fight over quality of coconut oil
Kerala touches a chord in western music buffs' hearts
SEBI approves demutualisation of CSE
MILMA, Popy top brands in State: Survey
B2B meet a big opportunity for industrial clusters
Rupee declines
Sensex scales new peak
Exchange rates
Bullion rates
Tatas withdraw petition
To pick up stake in Annik Tech
Yes Bank ties up with Alterra
GAIL venture in Bangladesh
SME Ratings' plans
Wealth Advisors opens branch
ABN AMRO-Max Healthcare launch co-branded card
Elcoteq Network enhances portfolio
GrapeCity in pact with Intel
Hughes signs agreement with Reliance
Usha Martin board nod for GDR issue
Horlicks variants launched
Wipro Infotech solution for Karnataka Bank
HLL launches flavoured tea
Jataayu in Red Herring Asia 100 list
Satyam selects Computer Associates' solution
Tentative nod for Aurobindo pharma drug
Eureka Forbes joins hands with BPCL
Le Meridien Tower Suites
Tata Indicom brings "Onagosham" offer

Copyright © 2005, The Hindu. Republication or redissemination of the contents of this screen are expressly prohibited without the written consent of The Hindu